0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global EGFR-TKI Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-16D18054
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global EGFR TKI Market Research Report 2024
BUY CHAPTERS

Global EGFR-TKI Market Research Report 2026

Code: QYRE-Auto-16D18054
Report
2026-02-13
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

EGFR-TKI Market

The global EGFR-TKI market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on EGFR-TKI competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
The North American market for EGFR-TKI is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for EGFR-TKI is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of EGFR-TKI include AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, Chengdu Brilliant Pharmaceuticals, Hansoh Pharma, ArriVent Biopharma, Hanmi Pharmaceutical, Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global EGFR-TKI market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding EGFR-TKI. The EGFR-TKI market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global EGFR-TKI market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist EGFR-TKI manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of EGFR-TKI Market Report

Report Metric Details
Report Name EGFR-TKI Market
Segment by Type
  • Gefitinib
  • Erlotinib
  • Icotinib
  • Afatinib
  • Dacomitinib
  • Osimertinib
  • Aumolertinib
  • Furmonertinib
  • Lazertinib
  • Other
by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, Chengdu Brilliant Pharmaceuticals, Hansoh Pharma, ArriVent Biopharma, Hanmi Pharmaceutical, Johnson & Johnson, Yuhan Corporation, Shanghai Allist Pharmaceuticals, Wanbang Biopharmaceuticals, Beacon Pharma, Drug International, Teva, Mylan, Glenmark Pharmaceuticals, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for EGFR-TKI manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines EGFR-TKI sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the EGFR-TKI Market report?

Ans: The main players in the EGFR-TKI Market are AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, Chengdu Brilliant Pharmaceuticals, Hansoh Pharma, ArriVent Biopharma, Hanmi Pharmaceutical, Johnson & Johnson, Yuhan Corporation, Shanghai Allist Pharmaceuticals, Wanbang Biopharmaceuticals, Beacon Pharma, Drug International, Teva, Mylan, Glenmark Pharmaceuticals, Cipla

What are the Application segmentation covered in the EGFR-TKI Market report?

Ans: The Applications covered in the EGFR-TKI Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the EGFR-TKI Market report?

Ans: The Types covered in the EGFR-TKI Market report are Gefitinib, Erlotinib, Icotinib, Afatinib, Dacomitinib, Osimertinib, Aumolertinib, Furmonertinib, Lazertinib, Other

1 EGFR-TKI Market Overview
1.1 Product Definition
1.2 EGFR-TKI by Type
1.2.1 Global EGFR-TKI Market Value by Type: 2025 vs 2032
1.2.2 Gefitinib
1.2.3 Erlotinib
1.2.4 Icotinib
1.2.5 Afatinib
1.2.6 Dacomitinib
1.2.7 Osimertinib
1.2.8 Aumolertinib
1.2.9 Furmonertinib
1.2.10 Lazertinib
1.3 EGFR-TKI by Application
1.3.1 Global EGFR-TKI Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global EGFR-TKI Market Size Estimates and Forecasts
1.4.1 Global EGFR-TKI Revenue 2021–2032
1.4.2 Global EGFR-TKI Sales 2021–2032
1.4.3 Global EGFR-TKI Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 EGFR-TKI Market Competition by Manufacturers
2.1 Global EGFR-TKI Sales Market Share by Manufacturers (2021–2026)
2.2 Global EGFR-TKI Revenue Market Share by Manufacturers (2021–2026)
2.3 Global EGFR-TKI Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of EGFR-TKI, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of EGFR-TKI, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of EGFR-TKI, Product Types and Applications
2.7 Global Key Manufacturers of EGFR-TKI, Date of Entry into the Industry
2.8 Global EGFR-TKI Market Competitive Situation and Trends
2.8.1 Global EGFR-TKI Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global EGFR-TKI Players Market Share by Revenue
2.8.3 Global EGFR-TKI Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global EGFR-TKI Market Scenario by Region
3.1 Global EGFR-TKI Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global EGFR-TKI Sales by Region: 2021–2032
3.2.1 Global EGFR-TKI Sales by Region: 2021–2026
3.2.2 Global EGFR-TKI Sales by Region: 2027–2032
3.3 Global EGFR-TKI Revenue by Region: 2021–2032
3.3.1 Global EGFR-TKI Revenue by Region: 2021–2026
3.3.2 Global EGFR-TKI Revenue by Region: 2027–2032
3.4 North America EGFR-TKI Market Facts & Figures by Country
3.4.1 North America EGFR-TKI Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America EGFR-TKI Sales by Country (2021–2032)
3.4.3 North America EGFR-TKI Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe EGFR-TKI Market Facts & Figures by Country
3.5.1 Europe EGFR-TKI Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe EGFR-TKI Sales by Country (2021–2032)
3.5.3 Europe EGFR-TKI Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific EGFR-TKI Market Facts & Figures by Region
3.6.1 Asia Pacific EGFR-TKI Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific EGFR-TKI Sales by Region (2021–2032)
3.6.3 Asia Pacific EGFR-TKI Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America EGFR-TKI Market Facts & Figures by Country
3.7.1 Latin America EGFR-TKI Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America EGFR-TKI Sales by Country (2021–2032)
3.7.3 Latin America EGFR-TKI Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa EGFR-TKI Market Facts & Figures by Country
3.8.1 Middle East and Africa EGFR-TKI Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa EGFR-TKI Sales by Country (2021–2032)
3.8.3 Middle East and Africa EGFR-TKI Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global EGFR-TKI Sales by Type (2021–2032)
4.1.1 Global EGFR-TKI Sales by Type (2021–2026)
4.1.2 Global EGFR-TKI Sales by Type (2027–2032)
4.1.3 Global EGFR-TKI Sales Market Share by Type (2021–2032)
4.2 Global EGFR-TKI Revenue by Type (2021–2032)
4.2.1 Global EGFR-TKI Revenue by Type (2021–2026)
4.2.2 Global EGFR-TKI Revenue by Type (2027–2032)
4.2.3 Global EGFR-TKI Revenue Market Share by Type (2021–2032)
4.3 Global EGFR-TKI Price by Type (2021–2032)
5 Segment by Application
5.1 Global EGFR-TKI Sales by Application (2021–2032)
5.1.1 Global EGFR-TKI Sales by Application (2021–2026)
5.1.2 Global EGFR-TKI Sales by Application (2027–2032)
5.1.3 Global EGFR-TKI Sales Market Share by Application (2021–2032)
5.2 Global EGFR-TKI Revenue by Application (2021–2032)
5.2.1 Global EGFR-TKI Revenue by Application (2021–2026)
5.2.2 Global EGFR-TKI Revenue by Application (2027–2032)
5.2.3 Global EGFR-TKI Revenue Market Share by Application (2021–2032)
5.3 Global EGFR-TKI Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca EGFR-TKI Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Roche EGFR-TKI Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Betta Pharma
6.3.1 Betta Pharma Company Information
6.3.2 Betta Pharma Description and Business Overview
6.3.3 Betta Pharma EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Betta Pharma EGFR-TKI Product Portfolio
6.3.5 Betta Pharma Recent Developments/Updates
6.4 Boehringer Ingelheim Pharmaceuticals
6.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
6.4.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
6.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolio
6.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Pfizer EGFR-TKI Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Chengdu Brilliant Pharmaceuticals
6.6.1 Chengdu Brilliant Pharmaceuticals Company Information
6.6.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview
6.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolio
6.6.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
6.7 Hansoh Pharma
6.7.1 Hansoh Pharma Company Information
6.7.2 Hansoh Pharma Description and Business Overview
6.7.3 Hansoh Pharma EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hansoh Pharma EGFR-TKI Product Portfolio
6.7.5 Hansoh Pharma Recent Developments/Updates
6.8 ArriVent Biopharma
6.8.1 ArriVent Biopharma Company Information
6.8.2 ArriVent Biopharma Description and Business Overview
6.8.3 ArriVent Biopharma EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ArriVent Biopharma EGFR-TKI Product Portfolio
6.8.5 ArriVent Biopharma Recent Developments/Updates
6.9 Hanmi Pharmaceutical
6.9.1 Hanmi Pharmaceutical Company Information
6.9.2 Hanmi Pharmaceutical Description and Business Overview
6.9.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hanmi Pharmaceutical EGFR-TKI Product Portfolio
6.9.5 Hanmi Pharmaceutical Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Company Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Johnson & Johnson EGFR-TKI Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Yuhan Corporation
6.11.1 Yuhan Corporation Company Information
6.11.2 Yuhan Corporation Description and Business Overview
6.11.3 Yuhan Corporation EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Yuhan Corporation EGFR-TKI Product Portfolio
6.11.5 Yuhan Corporation Recent Developments/Updates
6.12 Shanghai Allist Pharmaceuticals
6.12.1 Shanghai Allist Pharmaceuticals Company Information
6.12.2 Shanghai Allist Pharmaceuticals Description and Business Overview
6.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolio
6.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
6.13 Wanbang Biopharmaceuticals
6.13.1 Wanbang Biopharmaceuticals Company Information
6.13.2 Wanbang Biopharmaceuticals Description and Business Overview
6.13.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolio
6.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.14 Beacon Pharma
6.14.1 Beacon Pharma Company Information
6.14.2 Beacon Pharma Description and Business Overview
6.14.3 Beacon Pharma EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Beacon Pharma EGFR-TKI Product Portfolio
6.14.5 Beacon Pharma Recent Developments/Updates
6.15 Drug International
6.15.1 Drug International Company Information
6.15.2 Drug International Description and Business Overview
6.15.3 Drug International EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Drug International EGFR-TKI Product Portfolio
6.15.5 Drug International Recent Developments/Updates
6.16 Teva
6.16.1 Teva Company Information
6.16.2 Teva Description and Business Overview
6.16.3 Teva EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Teva EGFR-TKI Product Portfolio
6.16.5 Teva Recent Developments/Updates
6.17 Mylan
6.17.1 Mylan Company Information
6.17.2 Mylan Description and Business Overview
6.17.3 Mylan EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Mylan EGFR-TKI Product Portfolio
6.17.5 Mylan Recent Developments/Updates
6.18 Glenmark Pharmaceuticals
6.18.1 Glenmark Pharmaceuticals Company Information
6.18.2 Glenmark Pharmaceuticals Description and Business Overview
6.18.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Glenmark Pharmaceuticals EGFR-TKI Product Portfolio
6.18.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.19 Cipla
6.19.1 Cipla Company Information
6.19.2 Cipla Description and Business Overview
6.19.3 Cipla EGFR-TKI Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Cipla EGFR-TKI Product Portfolio
6.19.5 Cipla Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 EGFR-TKI Industry Chain Analysis
7.2 EGFR-TKI Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 EGFR-TKI Production Mode & Process Analysis
7.4 EGFR-TKI Sales and Marketing
7.4.1 EGFR-TKI Sales Channels
7.4.2 EGFR-TKI Distributors
7.5 EGFR-TKI Customer Analysis
8 EGFR-TKI Market Dynamics
8.1 EGFR-TKI Industry Trends
8.2 EGFR-TKI Market Drivers
8.3 EGFR-TKI Market Challenges
8.4 EGFR-TKI Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global EGFR-TKI Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global EGFR-TKI Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global EGFR-TKI Market Competitive Situation by Manufacturers in 2025
 Table 4. Global EGFR-TKI Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global EGFR-TKI Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global EGFR-TKI Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global EGFR-TKI Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market EGFR-TKI Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of EGFR-TKI, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of EGFR-TKI, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of EGFR-TKI, Product Types and Applications
 Table 12. Global Key Manufacturers of EGFR-TKI, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global EGFR-TKI Companies by Tier (Tier 1, Tier 2, Tier 3), based on EGFR-TKI Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global EGFR-TKI Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global EGFR-TKI Sales by Region (K Units), 2021–2026
 Table 18. Global EGFR-TKI Sales Market Share by Region (2021–2026)
 Table 19. Global EGFR-TKI Sales by Region (K Units), 2027–2032
 Table 20. Global EGFR-TKI Sales Market Share by Region (2027–2032)
 Table 21. Global EGFR-TKI Revenue by Region (US$ Million), 2021–2026
 Table 22. Global EGFR-TKI Revenue Market Share by Region (2021–2026)
 Table 23. Global EGFR-TKI Revenue by Region (US$ Million), 2027–2032
 Table 24. Global EGFR-TKI Revenue Market Share by Region (2027–2032)
 Table 25. North America EGFR-TKI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America EGFR-TKI Sales by Country (K Units), 2021–2026
 Table 27. North America EGFR-TKI Sales by Country (K Units), 2027–2032
 Table 28. North America EGFR-TKI Revenue by Country (US$ Million), 2021–2026
 Table 29. North America EGFR-TKI Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe EGFR-TKI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe EGFR-TKI Sales by Country (K Units), 2021–2026
 Table 32. Europe EGFR-TKI Sales by Country (K Units), 2027–2032
 Table 33. Europe EGFR-TKI Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe EGFR-TKI Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific EGFR-TKI Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific EGFR-TKI Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific EGFR-TKI Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific EGFR-TKI Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific EGFR-TKI Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America EGFR-TKI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America EGFR-TKI Sales by Country (K Units), 2021–2026
 Table 42. Latin America EGFR-TKI Sales by Country (K Units), 2027–2032
 Table 43. Latin America EGFR-TKI Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America EGFR-TKI Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa EGFR-TKI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa EGFR-TKI Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa EGFR-TKI Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa EGFR-TKI Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa EGFR-TKI Revenue by Country (US$ Million), 2027–2032
 Table 50. Global EGFR-TKI Sales (K Units) by Type (2021–2026)
 Table 51. Global EGFR-TKI Sales (K Units) by Type (2027–2032)
 Table 52. Global EGFR-TKI Sales Market Share by Type (2021–2026)
 Table 53. Global EGFR-TKI Sales Market Share by Type (2027–2032)
 Table 54. Global EGFR-TKI Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global EGFR-TKI Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global EGFR-TKI Revenue Market Share by Type (2021–2026)
 Table 57. Global EGFR-TKI Revenue Market Share by Type (2027–2032)
 Table 58. Global EGFR-TKI Price (US$/Unit) by Type (2021–2026)
 Table 59. Global EGFR-TKI Price (US$/Unit) by Type (2027–2032)
 Table 60. Global EGFR-TKI Sales (K Units) by Application (2021–2026)
 Table 61. Global EGFR-TKI Sales (K Units) by Application (2027–2032)
 Table 62. Global EGFR-TKI Sales Market Share by Application (2021–2026)
 Table 63. Global EGFR-TKI Sales Market Share by Application (2027–2032)
 Table 64. Global EGFR-TKI Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global EGFR-TKI Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global EGFR-TKI Revenue Market Share by Application (2021–2026)
 Table 67. Global EGFR-TKI Revenue Market Share by Application (2027–2032)
 Table 68. Global EGFR-TKI Price (US$/Unit) by Application (2021–2026)
 Table 69. Global EGFR-TKI Price (US$/Unit) by Application (2027–2032)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AstraZeneca EGFR-TKI Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Roche EGFR-TKI Product
 Table 79. Roche Recent Developments/Updates
 Table 80. Betta Pharma Company Information
 Table 81. Betta Pharma Description and Business Overview
 Table 82. Betta Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Betta Pharma EGFR-TKI Product
 Table 84. Betta Pharma Recent Developments/Updates
 Table 85. Boehringer Ingelheim Pharmaceuticals Company Information
 Table 86. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
 Table 87. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product
 Table 89. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Pfizer EGFR-TKI Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Chengdu Brilliant Pharmaceuticals Company Information
 Table 96. Chengdu Brilliant Pharmaceuticals Description and Business Overview
 Table 97. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product
 Table 99. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
 Table 100. Hansoh Pharma Company Information
 Table 101. Hansoh Pharma Description and Business Overview
 Table 102. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Hansoh Pharma EGFR-TKI Product
 Table 104. Hansoh Pharma Recent Developments/Updates
 Table 105. ArriVent Biopharma Company Information
 Table 106. ArriVent Biopharma Description and Business Overview
 Table 107. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. ArriVent Biopharma EGFR-TKI Product
 Table 109. ArriVent Biopharma Recent Developments/Updates
 Table 110. Hanmi Pharmaceutical Company Information
 Table 111. Hanmi Pharmaceutical Description and Business Overview
 Table 112. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Hanmi Pharmaceutical EGFR-TKI Product
 Table 114. Hanmi Pharmaceutical Recent Developments/Updates
 Table 115. Johnson & Johnson Company Information
 Table 116. Johnson & Johnson Description and Business Overview
 Table 117. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Johnson & Johnson EGFR-TKI Product
 Table 119. Johnson & Johnson Recent Developments/Updates
 Table 120. Yuhan Corporation Company Information
 Table 121. Yuhan Corporation Description and Business Overview
 Table 122. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Yuhan Corporation EGFR-TKI Product
 Table 124. Yuhan Corporation Recent Developments/Updates
 Table 125. Shanghai Allist Pharmaceuticals Company Information
 Table 126. Shanghai Allist Pharmaceuticals Description and Business Overview
 Table 127. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Shanghai Allist Pharmaceuticals EGFR-TKI Product
 Table 129. Shanghai Allist Pharmaceuticals Recent Developments/Updates
 Table 130. Wanbang Biopharmaceuticals Company Information
 Table 131. Wanbang Biopharmaceuticals Description and Business Overview
 Table 132. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Wanbang Biopharmaceuticals EGFR-TKI Product
 Table 134. Wanbang Biopharmaceuticals Recent Developments/Updates
 Table 135. Beacon Pharma Company Information
 Table 136. Beacon Pharma Description and Business Overview
 Table 137. Beacon Pharma EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Beacon Pharma EGFR-TKI Product
 Table 139. Beacon Pharma Recent Developments/Updates
 Table 140. Drug International Company Information
 Table 141. Drug International Description and Business Overview
 Table 142. Drug International EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Drug International EGFR-TKI Product
 Table 144. Drug International Recent Developments/Updates
 Table 145. Teva Company Information
 Table 146. Teva Description and Business Overview
 Table 147. Teva EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Teva EGFR-TKI Product
 Table 149. Teva Recent Developments/Updates
 Table 150. Mylan Company Information
 Table 151. Mylan Description and Business Overview
 Table 152. Mylan EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Mylan EGFR-TKI Product
 Table 154. Mylan Recent Developments/Updates
 Table 155. Glenmark Pharmaceuticals Company Information
 Table 156. Glenmark Pharmaceuticals Description and Business Overview
 Table 157. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Glenmark Pharmaceuticals EGFR-TKI Product
 Table 159. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 160. Cipla Company Information
 Table 161. Cipla Description and Business Overview
 Table 162. Cipla EGFR-TKI Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Cipla EGFR-TKI Product
 Table 164. Cipla Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. EGFR-TKI Distributors List
 Table 168. EGFR-TKI Customers List
 Table 169. EGFR-TKI Market Trends
 Table 170. EGFR-TKI Market Drivers
 Table 171. EGFR-TKI Market Challenges
 Table 172. EGFR-TKI Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of EGFR-TKI
 Figure 2. Global EGFR-TKI Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global EGFR-TKI Market Share by Type: 2025 & 2032
 Figure 4. Gefitinib Product Picture
 Figure 5. Erlotinib Product Picture
 Figure 6. Icotinib Product Picture
 Figure 7. Afatinib Product Picture
 Figure 8. Dacomitinib Product Picture
 Figure 9. Osimertinib Product Picture
 Figure 10. Aumolertinib Product Picture
 Figure 11. Furmonertinib Product Picture
 Figure 12. Lazertinib Product Picture
 Figure 13. Global EGFR-TKI Market Value by Application (US$ Million), 2021–2032
 Figure 14. Global EGFR-TKI Market Share by Application: 2025 & 2032
 Figure 15. Hospital and Clinic
 Figure 16. Retail Pharmacies
 Figure 17. Other
 Figure 18. Global EGFR-TKI Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global EGFR-TKI Market Size (US$ Million), 2021–2032
 Figure 20. Global EGFR-TKI Sales (K Units), 2021–2032
 Figure 21. Global EGFR-TKI Average Price (US$/Unit), 2021–2032
 Figure 22. EGFR-TKI Report Years Considered
 Figure 23. EGFR-TKI Sales Share by Manufacturers in 2025
 Figure 24. Global EGFR-TKI Revenue Share by Manufacturers in 2025
 Figure 25. Top 5 and Top 10 Global EGFR-TKI Players: Market Share by Revenue in EGFR-TKI in 2025
 Figure 26. EGFR-TKI Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 27. Global EGFR-TKI Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 28. North America EGFR-TKI Sales Market Share by Country (2021–2032)
 Figure 29. North America EGFR-TKI Revenue Market Share by Country (2021–2032)
 Figure 30. United States EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Canada EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Europe EGFR-TKI Sales Market Share by Country (2021–2032)
 Figure 33. Europe EGFR-TKI Revenue Market Share by Country (2021–2032)
 Figure 34. Germany EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. France EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. U.K. EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Italy EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Russia EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Asia Pacific EGFR-TKI Sales Market Share by Region (2021–2032)
 Figure 40. Asia Pacific EGFR-TKI Revenue Market Share by Region (2021–2032)
 Figure 41. China EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Japan EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. South Korea EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. India EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Australia EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. China Taiwan EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Southeast Asia EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Latin America EGFR-TKI Sales Market Share by Country (2021–2032)
 Figure 49. Latin America EGFR-TKI Revenue Market Share by Country (2021–2032)
 Figure 50. Mexico EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Brazil EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Argentina EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Colombia EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Middle East and Africa EGFR-TKI Sales Market Share by Country (2021–2032)
 Figure 55. Middle East and Africa EGFR-TKI Revenue Market Share by Country (2021–2032)
 Figure 56. Turkey EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Saudi Arabia EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. UAE EGFR-TKI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Global Sales Market Share of EGFR-TKI by Type (2021–2032)
 Figure 60. Global Revenue Market Share of EGFR-TKI by Type (2021–2032)
 Figure 61. Global EGFR-TKI Price (US$/Unit) by Type (2021–2032)
 Figure 62. Global Sales Market Share of EGFR-TKI by Application (2021–2032)
 Figure 63. Global Revenue Market Share of EGFR-TKI by Application (2021–2032)
 Figure 64. Global EGFR-TKI Price (US$/Unit) by Application (2021–2032)
 Figure 65. EGFR-TKI Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI